comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 11:46:27 - browse：48

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Phenylephrine and the overlooked value of the placebo effect

hotspot

WSS

How should state employee insurance handle Wegovy?

Female surgeons have lower rates of long

A revolution in caring for preterm infants

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

A Q&A with the global head of Boehringer Ingelheim's innovation unit

There’s no way to know how good AI health technologies are

Wikipedia

comprehensive

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

How clinical AI models' predictive power can degrade over time

Supreme Court strikes down use of affirmative action

Humana CEO Bruce Broussard to step down in 2024

In Memoriam: Notable people who died in 2023

What the Wegovy shortage looks like for doctors — and for patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Humana CEO Bruce Broussard to step down in 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Liquid biopsy for lung cancer is launched by Delfi

entertainment

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

A Q&A with the global head of Boehringer Ingelheim's innovation unit

FDA rejects Alnylam's heart disease treatment over insufficient data

Why age limits for politicians are a terrible idea

Life sciences deals on track to hit lowest point since 2017

When women are denied an abortion, their children fare worse than peers

hotspot

hotspot

hotspot

Wikipedia